Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling-Reference-Cited by-同舟云学术

Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling

Published:2017-02 Issue:2 Volume:8 Page:e2601-e2601
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Smulski Cristian R,Decossas Marion,Chekkat Neila,Beyrath Julien,Willen Laure,Guichard Gilles^ORCID,Lorenzetti Raquel,Rizzi Marta,Eibel Hermann,Schneider Pascal^ORCID,Fournel Sylvie

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis201722.pdf

Reference52 articles.

1. Koncz G, Hueber AO . The Fas/CD95 receptor regulates the death of autoreactive B cells and the selection of antigen-specific B cells. Front Immunol 2012; 3: 207.

2. Victora GD, Nussenzweig MC . Germinal centers. Annu Rev Immunol 2012; 30: 429–457.

3. Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R et al. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol Rev 2010; 237: 90–103.

4. Kondo E, Yoshino T . Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis. Pathol Int 2007; 57: 391–397.

5. Greil R, Anether G, Johrer K, Tinhofer I . Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools. J Leukoc Biol 2003; 74: 311–330.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Reviews and advances in inflammatory diseases and the tumor necrosis factor;Frontiers in Cell and Developmental Biology;2024-04-09

2. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake;Frontiers in Immunology;2024-02-19

3. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells;Science Immunology;2024-01-12

4. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

5. CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11